St John's Wort
Best-in-class: St. John's Wort
One of the few botanicals with antidepressant efficacy comparable to prescription medication in trials — and one of the most dangerous supplements in existence for drug interactions.
St John's Wort quick facts
| Suggested dose | 300 mg standardized extract three times daily in most trials. Give it 4–6 weeks. |
| How often | Three times daily |
| Who it's for | Mild-to-moderate low mood, in someone taking no other medication and after a proper conversation. |
Genuine efficacy in mild-to-moderate depression, established by meta-analysis. The interaction profile is why it is not first-line and it deserves stating plainly: it lowers blood levels of oral contraceptives, warfarin, immunosuppressants, antiretrovirals, some chemotherapy and many others — there are documented unplanned pregnancies and transplant rejections from this. Combined with an SSRI it risks serotonin syndrome. Never start it without checking every medication you take.
How St John's Wort actually works
Hyperforin inhibits reuptake of serotonin, noradrenaline and dopamine — a broad monoamine reuptake inhibition. Separately, and more consequentially, hyperforin is a potent activator of the pregnane X receptor, which induces CYP3A4 and P-glycoprotein expression. That induction is what causes the interactions, and it is a pharmacological property rather than an idiosyncrasy.
Where to get St John's Wort
Find St John's Wort on iHerb →The evidence for St John's Wort
Graded by what exists behind each claim.
✅ Clinically validated
- Cochrane and other meta-analyses show efficacy in mild-to-moderate depression comparable to standard antidepressants, with fewer side effects.
- Evidence in severe depression is weaker.
📊 Correlative data
- Long European folk use for low mood, and — unusually for a botanical — it became a first-line prescription treatment for mild-to-moderate depression in Germany, giving it real population-level exposure data.
- That same exposure generated the interaction signal: contraceptive failures, transplant rejections and antiretroviral failures reported in practice are how the CYP3A4 induction became widely known. Observational data found the harm the trials were too short to see.
🧪 Theoretical / extrapolated benefits
- Hyperforin inhibits reuptake of serotonin, noradrenaline and dopamine, plus other actions.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What St John's Wort actually does
The most important thing this plant does has nothing to do with mood. Hypericum perforatum is the most potent inducer of drug metabolism available without a prescription. Its extracts upregulate cytochrome P450 3A4 and P-glycoprotein, and because those 2 systems between them handle a large share of oral drugs, the interaction list is not a list of unusual drugs. It is a list of ordinary ones.
Induction runs through a nuclear receptor, which is why it takes days and lasts weeks. Hyperforin is a ligand for the pregnane X receptor, and modeling work characterizes it as a non-steroidal modulator of the pregnane X receptor to cytochrome P450 3A4 axis Sabarathinam 2025. A ligand-activated transcription factor increasing enzyme expression is a slow process in both directions: full induction takes 1 to 2 weeks, and the enzyme level does not return to baseline for a similar period after stopping. Every practical consequence below follows from that timescale.
And here is the finding that breaks the marketing. Low-hyperforin extracts are sold on the argument that removing hyperforin removes the interaction. In Wistar rats treated for 10 days with 400 mg per kilogram of a St John's wort preparation, cytochrome P450 3A messenger RNA rose about 1.8-fold, and the authors concluded that St John's wort formulations induce the enzyme independently of their hyperforin content, with the modulation most likely not linked to an interaction of hyperforin with the rat pregnane X receptor Schäfer 2023. If that holds in people, “low hyperforin, therefore safe with my medication” is not a conclusion the chemistry supports.
The transporter side has a tissue surprise in it. St John's wort extract increased P-glycoprotein expression in the brain of Wistar rats but not in the small intestine or the liver Taggi 2025. Intestinal P-glycoprotein controls how much of an oral drug is absorbed; brain P-glycoprotein controls how much reaches the central nervous system. Those are different consequences from 1 botanical, and the second is the one nobody screens for.
The antidepressant mechanism itself has moved. Analysis of hyperforin at the TRPC6 channel led to the development of a new class of antidepressant compounds El Hamdaoui 2022. TRPC6 is a non-selective cation channel, and activating it raises intracellular calcium and inhibits monoamine reuptake indirectly rather than by blocking a transporter. That is a genuinely different pharmacology from a selective serotonin reuptake inhibitor, and it is a better explanation than the older story of weak inhibition at several transporters at once.
Cell, rodent, human — and where it stops
The interaction chain is complete from receptor to case report, and that is rare. Ligand binding to the pregnane X receptor Sabarathinam 2025, enzyme induction in rodents Schäfer 2023, transporter induction in rodent tissue Taggi 2025, and a documented clinical literature of failed drug therapy Nobakht 2022. Very few supplements have every rung of that ladder.
The transplant literature is where the consequences are measured. A review of tacrolimus interactions with dietary supplements, herbs and food treats St John's wort as a serious interactant Miedziaszczyk 2022. Tacrolimus has a narrow therapeutic index and is a cytochrome P450 3A4 and P-glycoprotein substrate, so induction lowers its blood level and the clinical result is graft rejection. That is not a theoretical risk; it is the reason transplant units ask about herbal products by name.
The efficacy evidence is real and it is for a defined extract. Documentary analysis of Hypericum perforatum in depressive disorders finds support in mild to moderate presentations Otero 2024, and the broader review of traditional uses, clinical trials and drug interactions reaches the same 2-sided conclusion Nobakht 2022. The trials that produced that result used standardized extracts at specified daily doses, typically 600 to 900 mg, for 6 weeks or more.
The obstacle to transfer is the population, and it is the obstacle that matters most on this page. The positive trials enrolled people with mild to moderate depressive symptoms who were diagnosed and followed. They do not establish anything about severe depression, about people already taking a prescribed antidepressant, or about somebody self-treating a low mood without an assessment. Extending them to those situations is not conservative reading.
And the rodent-to-human step on induction is not closed. The hyperforin-independence result is in rats and in rat enzyme Schäfer 2023. Human pregnane X receptor and rat pregnane X receptor have different ligand preferences, which is exactly why the result needs a human replication before anybody declares low-hyperforin products either safe or unsafe. Stating that uncertainty is the honest position, and it is more useful than either marketing claim.
St John's Wort — which form, and does it matter
The form question here is the entire safety question, which makes this page unusual. St John's wort extracts are sold under manufacturer codes and standardization targets that differ in the 1 constituent that governs drug interactions. Some are standardized to hypericin, some to hyperforin, some to both, and some are deliberately produced low in hyperforin.
Hypericin standardization is a historical accident. Extracts have been standardized to 0.3 percent hypericin for decades because hypericin was the first compound isolated and is easy to measure by its color. Hypericin is not the antidepressant principle and it is not the enzyme inducer. A percentage of hypericin therefore tells you the extract is St John's wort and almost nothing else about how it will behave.
Hyperforin content is the number that was supposed to matter, and the rat data say it may not. Formulations induced the rat enzyme independently of hyperforin content Schäfer 2023, which undermines the safety argument for low-hyperforin products without supporting the opposite claim. The practical reading is that no St John's wort product should currently be treated as interaction-free, whatever its hyperforin specification says.
Tea, tincture and dry extract are 3 different exposures. Hyperforin is lipophilic and unstable, degrading on exposure to light and oxygen; hypericin is more stable; the flavonoids are water-soluble. An infusion made from loose herb extracts a different mixture from a 60 percent ethanol tincture, and both differ from a dry extract in a capsule. Dose comparisons across these formats are not meaningful.
And oil macerates are a fourth product entirely. The red oil made by steeping flowers in olive oil is used topically for wounds and nerve pain and carries a completely different constituent profile Nobakht 2022. It shares a common name with the capsules and nothing else.
What would have to be true, and how you would know it was not
1. The prediction that matters more than any mood measure. In somebody on a cytochrome P450 3A4 substrate with a measurable blood level — tacrolimus, ciclosporin, or a direct oral anticoagulant with an assay — predict the trough level falls within 14 days of starting St John's wort and takes a similar time to recover after stopping Miedziaszczyk 2022. That is the timescale of transcriptional induction and it is the reason stopping abruptly is its own risk.
2. Predict a failed contraceptive, and treat that as a measurement. Combined oral contraceptives are cleared by cytochrome P450 3A4, induction lowers ethinylestradiol exposure, and breakthrough bleeding is the observable early sign Nobakht 2022. Breakthrough bleeding starting within 2 to 3 weeks of starting a herbal product is a signal, not a coincidence, and the correct response is a barrier method and a pharmacist.
3. The efficacy prediction, with the marker named. Use a validated depression rating scale scored at baseline, 3 weeks and 6 weeks. Prediction from the controlled literature is a measurable improvement in mild to moderate presentations at 6 weeks and not at 1 Otero 2024. Anything that works within 3 days on this timescale is not the pharmacology.
4. Predict a photosensitivity threshold that most people never reach. Hypericin is a photosensitizer, and the classic ovine poisonings involved animals eating large quantities of the plant. In people at 900 mg of extract daily, predict no clinical photosensitivity, and predict that fair-skinned users on higher doses who report unusual sunburn are describing a real effect rather than a coincidence.
5. The prediction that would settle the low-hyperforin argument. Give a low-hyperforin and a standard extract to matched human volunteers and measure the midazolam clearance ratio, the standard human probe for cytochrome P450 3A4 activity, at day 14. If the 2 extracts induce equally, the rat finding transfers Schäfer 2023 and an entire product positioning collapses. This study is straightforward and has not been published.
What nobody has tested yet
Nobody has replicated the hyperforin-independence result in people. It is a rat result with a rat receptor Schäfer 2023 and a human probe study would answer it definitively. Until then, the safety difference between formulations is asserted by manufacturers rather than demonstrated.
Nobody knows what brain P-glycoprotein induction does clinically. Increased P-glycoprotein in the brain but not in gut or liver Taggi 2025 predicts reduced central exposure to drugs that are P-glycoprotein substrates, which would include several antipsychotics and antiepileptics, without changing their plasma levels. A drug level that looks therapeutic while brain exposure has fallen is a failure mode no monitoring currently detects, and no human study has looked.
Nobody has tested the TRPC6 mechanism therapeutically. The channel work produced new compounds rather than a trial of the plant acting through that channel El Hamdaoui 2022, so the link between the newly identified target and the observed clinical effect remains an inference.
And nobody has published a modern head-to-head at adequate power. Comparisons against selective serotonin reuptake inhibitors exist and are largely older and small Otero 2024. A contemporary non-inferiority trial with an active comparator and a prespecified interaction substudy would be the most useful trial anybody could run on this plant, and nobody is running it.
St John's Wort — its own safety story, not its category's
The risk that defines this product is a drug interaction, not a side effect. St John's wort is well tolerated on its own; the documented harm comes from what it does to other medicines. Induction of cytochrome P450 3A4 and P-glycoprotein lowers exposure to combined oral contraceptives, ciclosporin, tacrolimus, several antiretrovirals, warfarin, digoxin, some statins, direct oral anticoagulants and a number of oncology drugs Nobakht 2022 Miedziaszczyk 2022. The failure mode is a medicine quietly not working.
Serotonin syndrome is the other direction and it is additive. Combining St John's wort with a selective serotonin reuptake inhibitor, a serotonin-norepinephrine reuptake inhibitor, a triptan, tramadol or a monoamine oxidase inhibitor raises serotonergic tone from 2 directions at once. Agitation, tremor, sweating, hyperreflexia and fever within hours to days of adding it is a medical emergency rather than an adjustment period.
Stopping matters as much as starting, which almost nobody is told. Enzyme levels stay elevated for 1 to 2 weeks after the last dose, so a drug dose that was increased to compensate becomes an overdose as induction fades Sabarathinam 2025. Anybody whose medication was re-titrated while taking this plant needs the prescriber to know the date it was stopped.
Photosensitivity is real, dose-related and usually minor. Hypericin absorbs light and generates reactive oxygen species in skin. At ordinary supplement doses clinical photosensitivity is uncommon; fair-skinned people on high doses, and anyone having photodynamic or laser treatment, are the exceptions worth naming.
What this page will not do, stated plainly. It will not recommend this plant for depression, will not suggest anyone use it instead of prescribed treatment, and will not suggest anyone stop a prescribed medication. The trials that support it were run in diagnosed people under follow-up Otero 2024. Depression is a medical condition, self-treating it delays care, and worsening mood or thoughts of self-harm need a doctor or an emergency service the same day. No sentence above is medical advice or a diagnosis, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Schäfer AM. St. John's wort formulations induce rat CYP3A23-3A1 independent of their hyperforin content. Mol Pharmacol 2023 · PMID 37863663
- Sabarathinam S. Hyperforin as a Non-Steroidal Modulator of the PXR-CYP3A4 Regulatory Axis: Mechanistic and Computational Insights into Xenobiotic Metabolism. J Steroid Biochem Mol Biol 2025 · PMID 41192646
- Taggi V. St. John's Wort Extract Increases Pgp Expression in the Brain but Not in the Small Intestine or the Liver of Wistar Rats. Pharmacol Res Perspect 2025 · PMID 40325522
- El Hamdaoui Y. Analysis of hyperforin (St. John's wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs. Mol Psychiatry 2022 · PMID 36224261
- Nobakht SZ. Hypericum perforatum: Traditional uses, clinical trials, and drug interactions. Iran J Basic Med Sci 2022 · PMID 36246064
- Otero MC. Documentary Analysis of Hypericum perforatum (St. John's Wort) and Its Effect on Depressive Disorders. Pharmaceuticals (Basel) 2024 · PMID 39770466
- Miedziaszczyk M. Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food. Pharmaceutics 2022 · PMID 36297591
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: A daily mood score, plus one specific behavior you have been failing at — answering messages, leaving the house, cooking instead of ordering. Its trials ran on rating scales across weeks, and a score you fill in nightly beside a behavior you can count is the closest honest version of that.
- How long before it means anything: Four to six weeks at 300 mg of standardized extract three times a day, because that is the trial design. Stopping at week two is stopping before the evidence says anything is meant to have happened.
- What will fool you: What it is doing to your other medication, which you will not feel at all. It induces CYP3A4 and P-glycoprotein, and the documented consequences include contraceptive failure and unplanned pregnancy, transplant rejection, and antiretrovirals and anticoagulants quietly losing potency — none of which announce themselves the way a side effect does. If you take any prescription drug, this is a pharmacist conversation before the first capsule rather than after a bad outcome. And moderate-to-severe depression is not what this was tested in.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
St John's Wort — safety & side effects
- Photosensitivity — real sunburn risk in fair-skinned people. Dry mouth, restlessness and GI upset.
- The single most interaction-prone botanical there is. It induces CYP3A4 and P-glycoprotein and has caused documented failures of hormonal contraception, transplant anti-rejection drugs, antiretrovirals, warfarin and some chemotherapy. *Contraceptive failure is the one that catches people.*
- Do not start it without checking every medication you take against it. This is not a cautious caveat — the failures above are real reported cases.
The same on every page it applies to. Read it here; it is not repeated research.
- Do not combine with SSRIs, SNRIs, MAOIs, triptans or tramadol without medical supervision. Serotonin syndrome is rare but it is a genuine emergency — agitation, tremor, fever, rigidity — and the risk is additive rather than threshold-based.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — St John's Wort in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside St John's Wort
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
St John's Wort — frequently asked questions
What is St John's Wort?
One of the few botanicals with antidepressant efficacy comparable to prescription medication in trials — and one of the most dangerous supplements in existence for drug interactions.
What is the suggested dose of St John's Wort?
300 mg standardized extract three times daily in most trials. Give it 4–6 weeks. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find St John's Wort dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy St John's Wort?
Coach Cam sources St John's Wort from vetted, top-rated brands on iHerb — use the buy link on this page.
St John's Wort inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What St John's Wort is used for
St John's Wort appears under 1 goal in the goal router.
Related Cognitive & Mood supplements
Where this goes next
St John's Wort is the serotonergic arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.